Filters

CD58/LFA-3 Antibody

CD58/LFA-3 Antibody size: 0.1ml 263

Supplier BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price 263
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameCD58/LFA-3 Primary Polyclonal Antibody
Also known asCD58/LFA-3 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenCD58/LFA-3
SpecificityThis is a highly specific antibody against CD58/LFA-3
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range30-80/250
Subcellular locationExtracellular
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CD58
Gene ID number965
Swiss ProtP19256
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivityHuman
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen In addition, This interaction is important in mediating thymocyte interactions with thymic epithelial cells, antigen-independent and -dependent interactions of T-lymphocytes with target cells and antigen-presenting cells and the T-lymphocyte rosetting with erythrocytes, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells, Ligand of the T-lymphocyte CD2 glycoprotein
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names CD58, LFA-3, LFA3, Lymphocyte function-associated antigen 3, Surface glycoprotein LFA-3, ag3
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetCD58/LFA-3
Short nameCD58/LFA-3 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameCD58 molecule/LFA-3 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target CD58 and IDBG-101394 and ENSG00000116815 and 965, CD58 and IDBG-634482 and ENSBTAG00000040131 and 782186, Cell surfaces, ag3 and LFA-3 and LFA3, protein binding, this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0007155 and cell adhesion and biological process this GO :0007596 and blood coagulation and biological process this GO :0009986 and cell surface and cellular component this GO :0016020 and membrane and cellular component this GO :0016337 and single organismal cell-cell adhesion and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0034113 and heterotypic cell-cell adhesion and biological process this GO :0050900 and leukocyte migration and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0071346 and cellular response to interferon-gamma and biological process this GO :0071356 and cellular response to tumor necrosis factor and biological process this GO :2000484 and positive regulation of interleukin-8 secretion and biological process, this GO :0005102: receptor binding, this GO :0005102: receptor binding and also this GO :0005515: protein binding, this GO :0005515: protein binding, CD58 molecule
Identity 1688
Gene CD58
Long gene name CD58 molecule
Synonyms gene LFA3
Synonyms gene name (lymphocyte function-associated antigen 3) , CD58 antigen
Locus 1p13, 1
Discovery year 1989-04-06
GenBank acession BC005930
Entrez gene record 965
Pubmed identfication 9510189
RefSeq identity NM_001779
Classification CD molecules
Havana BLAST/BLAT OTTHUMG00000022749

Similar products

Subscribe to our Newsletter